Skip to main content

ANALISIS CUANTITATIVO DE ORGANOIDES DERIVADOS DE PACIENTES DE ALTO VALOR FISIOLOGICO: CARACTERIZACION IN VITRO, IN SITU E IN VIVO DE SU MORFOLOGIA Y FENOTIPO

PID2021-122409OB-C22

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION MEDICA APLICADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multimodal evaluation of drug antibacterial activity reveals cinnamaldehyde analog anti-biofilm effects against Haemophilus influenzae

  • Asensio-López, J.
  • Lázaro-Díez, María
  • Hernández-Cruz, T. M.
  • Blanco-Cabra, N.
  • Sorzabal-Bellido, I.
  • Arroyo-Urea, Eva María
  • Buetas, E.
  • González-Paredes, Ana
  • Ortiz de Solórzano, C.
  • Burgui, S.
  • Torrents, E.
  • Monteserín, M.
  • Garmendia, Juncal
Biofilm formation by the pathobiont Haemophilus influenzae is associated with human nasopharynx colonization, otitis media in children, and chronic respiratory infections in adults suffering from chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). β-lactam and quinolone antibiotics are commonly used to treat these infections. However, considering the resistance of biofilm-resident bacteria to antibiotic-mediated killing, the use of antibiotics may be insufficient and require being replaced or complemented with novel strategies. Moreover, unlike the standard minimal inhibitory concentration assay used to assess antibacterial activity against planktonic cells, standardization of methods to evaluate anti-biofilm drug activity is limited. In this work, we detail a panel of protocols for systematic analysis of drug antimicrobial effect on bacterial biofilms, customized to evaluate drug effects against H. influenzae biofilms. Testing of two cinnamaldehyde analogs, (E)-trans-2-nonenal and (E)-3-decen-2-one, demonstrated their effectiveness in both H. influenzae inhibition of biofilm formation and eradication or preformed biofilms. Assay complementarity allowed quantifying the dynamics and extent of the inhibitory effects, also observed for ampicillin resistant clinical strains forming biofilms refractory to this antibiotic. Moreover, cinnamaldehyde analog encapsulation into poly(lactic-co-glycolic acid) (PLGA) polymeric nanoparticles allowed drug vehiculization while maintaining efficacy. Overall, we demonstrate the usefulness of cinnamaldehyde analogs against H. influenzae biofilms, present a test panel that can be easily adapted to a wide range of pathogens and drugs, and highlight the benefits of drug nanoencapsulation towards safe controlled release., We are grateful to Alex Mira (FISABIO Foundation, Valencia, Spain) for providing access to the xCELLigence RTCA instrument. Funding Agencies and grant numbers: PhD studentship from Regional Navarra Govern, Spain, reference 0011-1408-2020-000007. Margarita Salas grant from Ministerio de Universidades, Spain, funded by the EU-Next Generation EU. This work has been funded by grants from AEI MICIU RTI2018-096369-B-I00, PID2021-125801OB-I00, MICIU PDI2021- 122409OB-C22; from SEPAR 875/2019; from Gobierno de Navarra PC150-151-152 and PC136-137-138; Atracción de Talento (Modalidad 1) program from Comunidad de Madrid, Spain, 2019-T1/IND-12906; Nanomedicine CSIC Hub, Spain, PIE202180E048. CIBER is an initiative from Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Automatic segmentation and quantification of Nigrosome-1 neuromelanin and iron in MRI: A candidate biomarker for parkinson's disease

  • Ariz Galilea, Mikel
  • Martínez, Martín
  • Álvarez, Ignacio
  • Fernández Seara, María Asunción
  • Castellanos, Gabriel
  • Catalonian Neuroimaging Parkinson's Disease Consortium
  • Pastor, Pau
  • Pastor, María A.
  • Ortiz de Solórzano, Carlos
Background: There is a lack of automated tools for the segmentation and quantification of neuromelanin (NM) and iron in the nigrosome-1 (N1). Existing tools evaluate the N1 sign, i.e., the presence or absence of the ‘swallow-tail’ in iron-sensitive MRI, or globally analyze the MRI signal in an area containing the N1, without providing a volumetric delineation. Purpose: Present an automated method to segment the N1 and quantify differences in N1's NM and iron content between Parkinson's disease (PD) patients and healthy controls (HCs). Study whether N1 degeneration is clinically related to PD and could be used as a biomarker of the disease. Study Type: Prospective. Subjects: Seventy-one PD (65.3 ± 10.3 years old, 34 female/37 male); 30 HC (62.7 ± 7.8 years old, 17 female/13 male). Field Strength/Sequence: 3 T Anatomical T1-weighted MPRAGE, NM-MRI T1-weighted gradient with magnetization transfer, susceptibility-weighted imaging (SWI). Assessment: N1 was automatically segmented in SWI images using a multi-image atlas, populated with healthy N1 structures manually annotated by a neurologist. Relative NM and iron content were quantified and their diagnostic performance assessed and compared with the substantia nigra pars compacta (SNc). The association between image parameters and clinically relevant variables was studied. Statistical Tests: Nonparametric tests were used (Mann-Whitney's U, chi-square, and Friedman tests) at P = 0.05. Results: N1's relative NM content decreased and relative iron content increased in PD patients compared with HCs (NM-CRHC = 22.55 ± 1.49; NM-CRPD = 19.79 ± 1.92; NM-nVolHC = 2.69 × 10-5 ± 1.02 × 10-5; NM-nVolPD = 1.18 × 10-5 ± 0.96 × 10−5; Iron-CRHC = 10.51 ± 2.64; Iron-CRPD = 19.35 ± 7.88; Iron-nVolHC = 0.72 × 10-5 ± 0.81 × 10-5; Iron-nVolPD = 2.82 × 10−5 ± 2.04 × 10−5). Binary logistic regression analyses combining N1 and SNc image parameters yielded a top AUC = 0.955. Significant correlation was found between most N1 parameters and both disease duration (ρNM-CR = -0.31; ρiron-CR = 0.43; ρiron-nVol = 0.46) and the motor status ρNM-nVol = -0.27; ρiron-CR = 0.33; ρiron-nVol = 0.28), suggesting NM reduction along with iron accumulation in N1 as the disease progresses. Data Conclusion: This method provides a fully automatic N1 segmentation, and the analyses performed reveal that N1 relative NM and iron quantification improves diagnostic performance and suggest a relative NM reduction along with a relative iron accumulation in N1 as the disease progresses. Evidence Level: 1. Technical Efficacy: Stage 1., The authors would like to thank all the subjects who participated in this study. This work was supported by Instituto de Salud Carlos III (ISCIII) and European Union NextGenerationEU/PRTR (grant number PMP22/00100) and by FEDER and the Spanish Ministry of Science and Innovation and Universities MCIN/AEI (10.13039/501100011033) (grant numbers PDI2021-122409OB-C22, RTI2018-094494-B-C22, and TED2021-131300B-I00 [C.O.S] and SAF2016-81016-R [M.A.P]). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and the final responsibility to submit for publication.